1. Home
  2. MRAM vs ARVN Comparison

MRAM vs ARVN Comparison

Compare MRAM & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Everspin Technologies Inc.

MRAM

Everspin Technologies Inc.

HOLD

Current Price

$19.14

Market Cap

512.1M

Sector

Technology

ML Signal

HOLD

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$8.39

Market Cap

516.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRAM
ARVN
Founded
2008
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
512.1M
516.2M
IPO Year
2016
2018

Fundamental Metrics

Financial Performance
Metric
MRAM
ARVN
Price
$19.14
$8.39
Analyst Decision
Strong Buy
Buy
Analyst Count
1
19
Target Price
$18.50
$15.05
AVG Volume (30 Days)
2.0M
771.2K
Earning Date
04-29-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
58.84
EPS
N/A
N/A
Revenue
$49,417,000.00
$262,600,000.00
Revenue This Year
$10.22
N/A
Revenue Next Year
$7.38
N/A
P/E Ratio
N/A
N/A
Revenue Growth
37.51
N/A
52 Week Low
$5.76
$6.06
52 Week High
$51.50
$14.22

Technical Indicators

Market Signals
Indicator
MRAM
ARVN
Relative Strength Index (RSI) 38.23 53.91
Support Level $8.77 N/A
Resistance Level $28.94 $10.18
Average True Range (ATR) 2.48 0.44
MACD -0.52 0.17
Stochastic Oscillator 3.08 81.76

Price Performance

Historical Comparison
MRAM
ARVN

About MRAM Everspin Technologies Inc.

Everspin Technologies Inc is a manufacturer of Magnetoresistive Random Access Memory (MRAM) technology. The company manufactures MRAM products using both captive and third-party manufacturing capabilities. It purchases industry-standard complementary metal-oxide semiconductor (CMOS) wafers from semiconductor foundries and perform back end of line (BEOL) processing that includes magnetic-bit technology at leased 200mm fabrication facility in Chandler, Arizona. It also manufactures full-flow 300mm CMOS wafers with STT-MRAM magnetic-bit technology integrated in BEOL. The company's customers are in key markets, such as industrial, medical, automotive/transportation, aerospace, and data center.

About ARVN Arvinas Inc.

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

Share on Social Networks: